We’re thrilled to announce that Virufy will be participating in Mobile Developers Week 2025! The event will bring together the world’s leading mobile development communities at the @Abu Dhabi Energy Center. We look forward to sharing more soon—stay tuned for more information!

Honored to be featured by our partners @Dubai_Health at #GITEXGlobal2025! Our AI-powered cough analysis app was showcased as a key digital initiative for accessible respiratory screening. A major step forward for public health innovation in the UAE. https://t.co/xHt2rHj2dJ

🌍 Today is World Mental Health Day. At Virufy, we know that living with illness can take a toll on the mind. That’s why our mission to harness AI for early disease detection and accessible healthcare goes beyond technology — it’s about caring for the whole person. 💚Happy WMHD!

Pneumonia, an infection that inflames air sacs in the lungs, threatens children, older adults and others. Virufy aims to identify breathing patterns and help differentiate pneumonia from other respiratory illnesses. DM us to support our mission in advancing pneumonia detection.

RSV causes 33 million cases in children under 5 each year. Often mistaken for a cold, RSV can escalate quickly. Virufy is exploring AI’s ability to differentiate RSV from other respiratory conditions. DM us to find out how you can support research to protect the most vulnerable.

Seasonal influenza affects 13 billion people annually. Hospitals face annual spikes that overwhelm care systems. @Virufy's AI could help patients seek care faster and reduce the spread. Support pioneering research that could reimagine flu detection. https://t.co/2W1ylnLF6J

COPD affects over 390 million people worldwide and is a leading cause of death. Early detection is critical, but it often goes undiagnosed. Virufy is training AI algorithms to recognize breathing patterns early on. Support us in advancing research to transform COPD detection.

Over 260 million people live with asthma. Attacks are often preventable if warning signs are caught early. Virufy’s AI research is developing technology that will aim to identify breathing irregularities before they escalate. Support our research: https://t.co/2W1ylnMcWh

Lessons from a Global Pandemic 🦠 Virufy’s AI was designed to screen coughs for COVID-19. This work inspired us to expand our efforts to detect other respiratory diseases. “Support our journey from pandemic response to future-proofing global health.” ▶️ https://t.co/2W1ylnMcWh

Virufy founder and president Amil Khanzada will speak at WHX Tech this Sept 10th at the Dubai World Trade Centre. 🎯 Topic: Why isn’t Generative AI moving beyond chatbots in healthcare — and what’s holding it back? When: Sept 10, 2025 📍 Where: World X Stage, WHX Tech, Dubai 🌍

Virufy has been featured on #VentureBlick’s VB Discovery platform! This is a fantastic opportunity to showcase our AI-driven health innovation to a global network of experts, investors, and partners. Looking forward to connecting with fellow innovators and growing together!

Virufy is eligible to participate as a 2025 #HalfMyDAF grantee! This recognition honors our mission of detection & prevention of respiratory diseases, and opens up an opportunity for matching grants. Learn more at https://t.co/ovg8Q4O3Lr Donate to Virufy:

We are thrilled to welcome Tom Mahoney to Virufy! Tom brings a wealth of experience at the intersection of life sciences, global health, and digital innovation, and will play a key role in shaping our mission to transform healthcare through AI-powered respiratory diagnostics.

Virufy has been selected as an awardee for Microsoft's AI for Good Open Call! This funding will help us leverage AI to develop a screening tool for underrecognized respiratory conditions like pneumonia. Excited to work with Microsoft's scientists to grow our impact in WA state!

Early #COPD diagnosis improves quality of life. #COPD is characterized by persistent airflow limitation. The global burden of disease study showed that COPD affected 174 million patients in 2015. Your donation can save lives: https://t.co/Xvyvhjv4FK #virufy, #aihealth, #donate

Virufy was one of 25 U.S. organizations in the trade mission, showcasing AI‑driven diagnostics that turn any smartphone into a rapid, privacy‑preserving screening tool for respiratory threats, with the UAE as the launch hub. 🔗 https://t.co/TpBtnSjiZL #HealthTech #AI

渡航費、滞在費支給で現地で働けるチャンス。 【協力】 皆さん、こんにちは！🌍 スタンフォード大学でAIを学んできた現在福井大学の博士課程学生のカンザダあみるです。 Virufyという 250人のボランティアスタッフがいるNPO法人 の代表を務めています。私たちは

あけましておめでとうございます！新年をいかがお過ごしですか？年の初めにアプリのリリースにご協力いただけませんか。Virufyアプリはコロナ患者との咳の類似性を知ることができるサービスです。寄付方法は下記リンクから！ https://t.co/MjmJCGMDMr 　 #Virufy #コロナ #NPO #寄付

#カリフォルニア 発 のNPO法人Virufy（ヴィルファイ）です。咳の音声から病気を検知するアプリを世界各国のメンバーと共に開発しています。Virufyを知ってもらえるように、X投稿していきます！#Virufy #コロナ

A great thank you to the @BARDA accelerator division of the U.S. Department of Health and Human Services for investing in us! We continue to welcome medical, marketing, and technology organizations to partner with us on addressing the pandemic.